Neutron-activated mercuric oxide was administered by gavage to female BALB/c mice. Counts of 19'Hg and 203Hg in the whole body, urine, and feces were followed for up to 36 days. Elimination of mercury fitted 8 3-compartment model. Nonpregnant mice eliminated approximately 87.5% of the dose at a fast rate (tl12 = 9 hours), 12% at an intermediate rate (tl12 = 2 days), and 0.5% at a slow rate (till = 15 days). Each half-time was approximately 7 times shorter than the corresponding half-time fitted to published data on rats. Mice were also faster than humans in eliminating the ingested mercury.
INTRODUCTION HE possibility that mice maintain an effective placenta1 barrier to inorganic mercurials was T raised by studies of prenatal toxicity. Teratogenic and embryotoxic effects have been produced in hamsters and rats by doses of mercuric oxide or mercuric nitrate that had minimal adverse effects on the pregnant females. In mice, by contrast, doses in the acutely lethal range were not directly fetolethal or teratogenic to litters of survivors, even though most of the mothers showed signs of toxicity. ( I ) Prenatally exposed mice were consequently either less susceptible to mercury poisoning or exposed to smaller tissue dosages than their mothers. To resolve these alternatives, we used an exten- sive series of toxicity tests as a data base,") replicated some of the tests with radioactively labeled mercuric oxide, and measured the body burdens, elimination, and tissue distribution of mercury in nonpregnant and pregnant mice, and the body burdens in prenatally exposed young. The objectives were to compare the rate constants of elimination of mercury by mice with those reported for rats and humans (as reviewed in the discussion section of this article), and to determine the partition of mercury between maternal tissues and the fetus. Body burden data were fitted to a compartmental model of elimination of mercury. Distributions of mercury in tissues and excreta were interpreted as clues to the physiological mechanisms that limited the uptake of mercurials by the prenatally exposed litters.
MATERIALS AND METHODS
Yellow mercuric oxide powder (Baker Analyzed) was neutron-activated to 1.55 pCi 203Hg per gram at the Nuclear Science Technology Facility (State University of New York at Buffalo), diluted with the parent HgO and aged to a specific activity of 0.64 pCi lo3Hg and 1.8 pCi 19'Hg per gram. Further dilutions of the tracer were tested and discarded, because they conferred no detectable radioactivity on prenatally exposed litters. An Armac chamber (Packard Model 446) with a scintillation spectrometer (Model 3002) was used to measure gamma ray emissions from animals and excreta with a counting efficiency of 33%. Plexiglas holders were fitted to the chamber so as to maintain a uniform counting geometry. A Packard Auto-Gamma counter with a Model 3002 spectrometer and a counting efficiency of 57% was used for tissue samples, which were packed in the bottom 3 cm of 12 x 75 mm test tubes and counted fresh. Duplicate counts were taken in lg7Hg and *"lHg channels against standards prepared from the mercuric oxide suspension that was used for dosing.
The experimental protocol replicated concurrent tests of prenatal toxicity of mercuric oxide to mice.") In brief, radioactively labeled HgO was suspended in a paste of vegetable shortening (Crisco, Procter and Gamble) and dispensed by gavage. IS BALB/c females weighinglan average of 25.5 g (f 1 S.D. = 3.6 g) received single doses of 30 pg HgO/g. Of these, 6 were not pregnant, 3 were dosed on day 8 of gestation, 3 on day 9, and 3 on day 10. One mouse died 6 days after dosing. Mice were anesthetized with a lethal dose of pentobarbital sodium (10 mg I.P.), exsanguinated by cardiac puncture, and dissected at times ranging from 2 to 36 days after dosing, with 2 out of 3 from each group of pregnant mice dissected on day 17 of gestation (17.5 days post-impregnation) and 6 dissected not pregnant. Simple and serviceable metabolic cages were made from 4 parts: a standard cage lid with feeder (Lab. Products Inc. Model 20121). a pair of polycarbonate mouse cages (Lab.
Products Inc. Model 10027), and a 6%" x 10%" floor plate cut out of a sheet of expanded stainless steel (%" mesh, 14 gauge) to provide flat supporting surfaces for feet. The cages were stacked; the bottom was cut out of the upper cage, except for 4 small flanges shaped to support the floor plate. The bottom of the lower cage was lined with a piece of plastic-coated absorbent paper (Kimpak, absorbent side up), which kept fecal pellets on the surface, absorbed urine, and dried promptly. One or 2 mice were housed per cage. At the end of a collection period, mice were measured for radioactivity and transferred to a fresh cage. Fecal pellets were collected off the liner. The metal floor and the inner sides of the plastic cages were swabbed clean with wet tissues. The tissues and the pellet-free liner were rolled into a packet and counted for the tracer in the urine. Elimination of mercury was modeled by compartmental analysis of body burden measurements.(2) Three rate constants were required to fit the observations over periods longer than 2 weeks. The equation represented a three-compartment model: exp (kd) 2. tllZ = (In 0.5)/k where P, was the percent of initial body burden remaining at time t, index numbers 1 through 3 marked 3 independent compartments for retention of mercury in the body, the parameter A corresponded to the initial percent distribution, and k to the exponential coefficient of elimination from each compartment, and tllZ values were the corresponding half-times of elimination.
The "initial delay" of elimination of mercury (drawn as a horizontal segment at the start of each elimination curve) was not added as a seventh parameter of the curve fitting model. On the contrary, it was obtained by deleting the constraint that the curve must originate from the initial body burden at t = 0 (in terms of the model, it meant deleting the constraint that A, + Al + A, = 100%).
Consequently, the reference body burden was plotted not as a point but as a segment, extending from the time of gavage (t = 0), to the time (t = d) where the fitted curve passed through P, = 100 percent. This interval was interpreted as the time elapsed before the mouse started to eliminate mercury. Equation parameters were fitted to data with inverse square weighing of P, valuesc3) and curves were plotted by MLAB routines'') on a DEC 10 computer with a graphics terminal. To adapt MLAB to curve stripping, the slowest elimination parameters (As and KJ were fitted first to the tail end of the curve; then the faster parameters and the earlier segments of the curve were added stepwise and the parameters were refitted. The robustness of the curve-fitting procedure was demonstrated by the consistency of parameters derived for individual mice and groups of mice. The differences between elimination rate constants were tested for significance by the approximate t-test for 2 means with independent sample sizes and independent variances. (')
RESULTS
No mercury was lost from the body for half a day after gavage ( Table 1) . After the initial delay, mercury was eliminated at a rate proportional to the remaining body burden with three time constants: a fast half-time of the order of nine hours; an intermediate one of the order of two days; and a slow one of the order of 2 weeks ( Table 1) . As noted in Methods, the partition of the body burden between the "fast," "intermediate," and "slow" compartments was calculated after correcting for the initial delay of elimination. Approximately 12% of mercury was eliminated at the intermediate rate, and only 0.5% lingered to be eliminated at the slow rate. Overall, the mice lost half of the ingested mercury in one day, 90% in 2% days, and 99% in 9 days. The time course of elimination is illustrated in Figure 1 . The mice in that figure were the subgroup with the shortest retention times for mercury; the corresponding till values for the full group are found in Table 1 .
Relative compartment sizes were not changed by gestation, but elimination became slower in pregnant females with the approach to term. This was traced in two ways to a slowing of the intermediate rate of elimination. When pregnant mice sacrificed on day 17 were compared with nonpregnant females, the fast elimination rate was unchanged, but the average tllr values of intermediate rates for the 2 groups were significantly different (p c .01) ( Table 1) . When one pregnant mouse was followed for 10 days before and 4 weeks after parturition, the intermediate rate of elimination changed sharply at parturition, from a longer till associated with gestation to a shorter one close to the average value for nonpregnant mice (Figure 2) .
All of the mercury lost from the body was recovered in urine and feces: in 5 mice an apparent average of 100.2% of the initial body count was recovered in 4 to 5 weeks in the collected urine and feces (range 100% to 100.5%) ( Figure 3 ). Nine times more mercury came out in the feces than in urine (average 90.2% of the total in feces, range 89-93%). The cumulative outputs up to 3.8 days after dosing from mice in Figure 3 averaged 84% of the dose in feces (range 82-88% percent) and 7.5% in urine (range 4.8-8.6%). The average daily output of mercury in feces was reduced to levels close to those in urine after the first week, but did not drop below the urine output.
Organ concentrations of mercury were followed in 12 animals sacrificed serially (Figure 4 ). All Figure 1 . The break between curves (arrow) marks the delivery of the litter. "Fast," "gravid," and "slow" elimination parameters were fitted to data before delivery, while "postpartum" and "slow" elimination parameters were fitted to data after delivery. The curve after delivery was fitted to only 2 compartments, since the fraction of mercury remaining in &he "fast" compartment was negligible by that time. o -1 mouse in the cage A, x -2 mice per cage (body burdens of 3 of these mice are shown in Figure 1 )
Three curvescombined recoveries in urine and feces for each cage. , small intestine ( x ) and brain (0). Data on days 6 through 9 are from the same mice as the data in Figure 5 . Derivation of the plotted curves is explained in the text. organs except the brain reached peak concentrations of mercury within 2 days after dosing. In brains, peak concentrations were found on the seventh day. Rankings, from highest to lowest, of concentrations of mercury per wet weight were as follows: Kidneys, liver, whole body, small intestine, uteri, integument, skeletal muscle, brain. Organs differed from each other in the pattern of loss of mercury. A useful approximation of organ-specific rates of loss was obtained by fitting the time sequence of mercury concentrations to a 2-component exponential decay equation:
The fitted curves (Equation 3) for kidneys, liver, small intestine, and brain were drawn in Figure 4 . In terms of the rate constant k,, the initial rate of loss of mercury was slowest in kidneys (till = 3.5 days), with progressively faster rates in uteri (till = 2.7 days), liver (till = 1.5 days), and small intestine (till = 1 day). Initial half-times for loss of mercury from the brain and integument were also of the order of one day. The difference between kidneys and liver was statistically significant (p < .Ol), as was the difference between the liver and the intestine (p c .05).
Whole body concentrations of mercury were plotted in Figure 4 for a qualitative comparison of patterns of elimination. The last recorded whole-body concentrations of organ donors were plotted as points. The body burden curves were drawn according to Equation 1, using the elimination rate constants listed in Table 1 . The loss of mercury from pregnant mice (Table 1, col. 2) was illustrated by the upper segment, the loss from post-partum or nonpregnant mice ( Table 1, Table 2 ). Eleven days after dosing, and with only 1.4% of the initial dose remaining in the dam, the newborn pups showed 25% of the maternal concentration of mercury.
DISCUSSION

Body Burdens
The tracer experiments examined the low end of the dose range used for toxicity tests.") One of 15 mice succumbed to poisoning, as would be expected from a dose equal to LD8 in these tests.
Analysis of plots of body burdens over time by curve stripping yielded three distinct rates of elimination, The time course of loss of mercury had been measured previously in rats after intramuscular or intravenous administration of mercuric nitrate. (5) We calculated the elimination rates of rats from the published data by curve stripping and found: These figures were for intramuscular administration but they remained quite similar for intravenous administration; for example, the half-time for slow elimination was never less than 90 days in rats. Mice, as reported here, eliminated mercury much faster in two ways: elimination half-times from each of the 3 compartments were between 7 and 8 times shorter than from the matching compartment in rats, and the body burden was distributed differently, with a strong bias toward the faster compartments ( Table 1 ). The fact that mice received their dose of mercury by mouth might account for a bias in distribution toward a rapidly cleared compartment, but only faster rates of excretion of mercury could account for the disparity of all 3 pairs to tl12 values between mice and rats.
A human subject who inhaled mercuric oxide also showed a 3-compartment pattern of elimination, with published half-times of the order of 1 day, 20 days, and 80 days; his body burden was partitioned between the intermediate and slow compartments in a ratio of 58:42V0.(~) Humans who ingested tracer mercuric nitrate eliminated 85% of the dose in 4 to 5 days; the remainder was eliminated at an exponential rate reported to fit a single half-time of 42 days.") This meant, that 36 days after ingesting a mercuric salt people retained an average of 8.8% of the dose (95% confidence limits 7.9W to 9.5%), while mice retained somewhat less than 1070. The tracer method used on human subjects was not designed to detect the long-term retention of a small fraction of the dose (1% or less), but other data indicated some retention in such a third Consequently, while ingested mercury was unequivocally eliminated more slowly by humans than by mice, the patterns of elimination seemed alike in the 2 species. Human elimination data fitted readily into a slow compartment, an intermediate compartment (tl12 = 42 days), and a fast compartment (tli2 = 1 day), with percent distribution among compartments resembling closely the distribution in mice ( Table 1 ).
Excretion
People dosed with inorganic mercurials by mouth"' excreted mercury in urine more slowly than mice (less than 2% of the dose up to 5 days); elimination in feces was also slower (85% of the dose up to 5 days). Excretion was also slower in rats than in mice. Urinary excretion by rats after a subtoxic, parentera) dose of an inorganic mercurial averaged 0.4% of body burden per day, and fecal elimination was. proportionally scaled down, so that the feces-to-urine ratios resembled the 9: 1 ratio found in our mice in spite of differences in species, doses, and routes of administration.(5*8) Inorganic mercury salts were shown to be choleretic as well as diuretic.'9' In rats a higher proportion of mercurywas excreted in urine at higher doses.(5.10)
Organ Distributions
Mercury derived from ingested HgO was selectively concentrated in mouse kidneys, as reported for other inorganic mercurials. ( I 1 -l 3 ) Bioconcentration was also recorded in kidneys of humans and rats, but there the period of accumulation was longer and the subsequent rate of loss was slower. In our data, the peak of accumulation was reached in mouse kidneys within 2 days, and the subsequent loss had a tllZ of less than 4 days. Comparable data on human kidneys showed accumulation for 11 days and a subsequent loss with a tllZ longer than 35 days. (6) In rat kidneys, accumulation continued for 15 days or more regardless of route of administration of the single do~e.'~.'') Only in seleniumdeficient rats(*) were the kinetics of mercury in kidneys similar to those reported here for normal mice.
Livers and placentae provided the two major reservoirs for mercury after kidney^.(^^-'^) Mouse liver lost mercury faster than the kidneys (Figure 4) . Brains and near-term fetuses had the lowest concentrations of mercury. A blood-brain barrier impeded the transfer of mercuric ion complexes so effectively that full equilibration was not reached for more than 2 weeks in rats.(s,ls) The same barrier was demonstrated in mice. (Iz) The observation that mercury levels of mouse brains equilibrated with the rest of the body and began to fall within a week after dosing (Figure 4 ) could be accounted for by the observation that body burdens fell much faster in mice than they did in rats.
Barriers delaying the transfer of inorganic mercurials were also located in mice between the yolk sac and chorioallantoic placenta on one side, and fetal blood on the The resulting maternal-fetal and placental-fetal distributions resembled those reported here. Similar placental barriers were found in other small mammals.~'6-'8) The apparent difference between mice and other species was, that mice eliminated most of their body burden of mercury before it had time to equilibrate across the placenta, so that concentrations in the mouse fetus approached maternal concentrations that had fallen to only a small fraction of the dosage. Our data supported the inference that mice, exposed to a single dose of an inorganic mercury compound, shielded their litters from prenatal damage by the action of a normally functioning placental barrier in conjunction with ah unusually rapid excretion of mercury.
Physiological Mechanisms
In order to derive information on prenatal toxicity of mercuric oxide to people from experiments on mice, an experimenter needs to define the maternal-fetal distributions and fetal doses of mercury that may be associated with human exposures, and reproduce such distributions in mice. The 3-compartment equation of elimination presented in this report could serve as the first step toward the formulation of a realistic toxicokinetic model needed for such a task. The data on excretion and organ distribution of mercury provided clues to the physiological parameters that would be represented in the model. (') The long-term retention of mercury appeared to be associated with an intracellular pool of mercury-binding proteins, such as the metallothioneins found in kidneys, liver, and placentae. (19) (20) (21) The difference reported here between the losses of mercury from kidneys and liver may be the same as for exposure to HgCL where metallothionein synthesis was induced in kidneys but not in the liver.{Z2)
As all the mercury ingested by mice was recovered in urine and feces, 2 routes were available for removing mercury from arterial blood: clearance into urine, and clearance into digestive system Fecal elimination could accommodate all of the mercury removed at the fast rate.
Both urinary excretion and fecal elimination were required, in varying proportions, to account for the mercury lost at intermediate and slow rates. The fecal output was a function of absorption and enterohepatic circulation: part of the ingested dose passed unabsorbed through the gastrointestinal tract, part was retained in gut tissues, part was absorbed into portal blood, and a part of the absorbed fraction was returned from the portal blood to the lumen by way of hepatic clearance into bile. The net enterohepatic clearance into feces was shown experimentally to be the rate-limiting step in the elimination of mercury even when HgCh was injected into rats.(z4) How much of the ingested mercury was similarly recycled into feces and how much passed through the lumen unabsorbed? This could not be estimated from simple 2-compartment") or 3-compartment (Table 1 ) models of elimination. A relevant toxicokinetic model would require data on mercury levels in hepatic portal blood, systemic blood, and
The data reported here disclosed a variety of differences in pharmacokinetics of inorganic mercurials between mice on one hand, and rats and humans on the other. The possibility is still open, that all these differences may be traced with the help of a compartmental model to a species difference in just one of the mechanisms that control the fate of mercury in the body.
